1. Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders. (25th November 2016) Authors: Wehling, C; Amon, O; Bommer, M; Hoppe, B; Kentouche, K; Schalk, G; Weimer, R; Wiesener, M; Hohenstein, B; Tönshoff, B; Büscher, R; Fehrenbach, H; Gök, Ö-N; Kirschfink, M Journal: Clinical and experimental immunology Issue: Volume 187:Number 2(2017:Feb.) Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗